The miR-200 family and the miR-18396182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers (original) (raw)

• Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9–29.
  Article Google Scholar
• Huber MA, Kraut N, Beug H . Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548–558.
  Article CAS Google Scholar
• Zheng H, Kang Y . Multilayer control of the EMT master regulators. Oncogene 2014; 33: 1755–1763.
  Article CAS Google Scholar
• Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487–1495.
  Article CAS Google Scholar
• Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927–939.
  Article CAS Google Scholar
• Yang J, Weinberg RA . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818–829.
  Article CAS Google Scholar
• Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G . A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene 2007; 26: 6896–6904.
  Article CAS Google Scholar
• Ahn YH, Gibbons DL, Chakravarti D, Creighton CJ, Rizvi ZH, Adams HP et al. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J Clin Inves 2012; 122: 3170–3183.
  Article CAS Google Scholar
• Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009; 23: 2140–2151.
  Article CAS Google Scholar
• Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W, Thilaganathan N et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest 2011; 121: 1373–1385.
  Article CAS Google Scholar
• Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP . The impact of microRNAs on protein output. Nature 2008; 455: 64–71.
  Article CAS Google Scholar
• Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
  Article CAS Google Scholar
• Djuranovic S, Nahvi A, Green R . miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012; 336: 237–240.
  Article CAS Google Scholar
• Fabian MR, Sonenberg N . The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586–593.
  Article CAS Google Scholar
• Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N . Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58–63.
  Article CAS Google Scholar
• Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68: 7846–7854.
  Article CAS Google Scholar
• Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582–589.
  Article CAS Google Scholar
• Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593–601.
  Article CAS Google Scholar
• Li XL, Hara T, Choi Y, Subramanian M, Francis P, Bilke S et al. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 2014; 34: 533–550.
  Article Google Scholar
• Lowery AJ, Miller N, Dwyer RM, Kerin MJ . Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 2010; 10: 502.
  Article Google Scholar
• Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X et al. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med 2012; 30: 1013–1020.
  Article CAS Google Scholar
• Sarver AL, Li L, Subramanian S . MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 2010; 70: 9570–9580.
  Article CAS Google Scholar
• Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, Kye MJ et al. Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 2012; 123: 539–552.
  Article CAS Google Scholar
• Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M . Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013; 328: 198–206.
  Article CAS Google Scholar
• Lam EW, Brosens JJ, Gomes AR, Koo CY . Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 2013; 13: 482–495.
  Article CAS Google Scholar
• Nilsson J, Helou K, Kovacs A, Bendahl PO, Bjursell G, Ferno M et al. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res 2010; 70: 2020–2029.
  Article CAS Google Scholar
• Ormestad M, Astorga J, Landgren H, Wang T, Johansson BR, Miura N et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006; 133: 833–843.
  Article CAS Google Scholar
• Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 2013; 19: 279–290.
  Article CAS Google Scholar
• Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn YH, Byers LA et al. Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun 2014; 5: 5241.
  Article CAS Google Scholar
• Betel D, Koppal A, Agius P, Sander C, Leslie C . Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010; 11: R90.
  Article Google Scholar
• Betel D, Wilson M, Gabow A, Marks DS, Sander C . The microRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36: D149–D153.
  Article CAS Google Scholar
• Brabletz S, Brabletz T . The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11: 670–677.
  Article CAS Google Scholar
• Browne G, Sayan AE, Tulchinsky E . ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle 2010; 9: 886–891.
  Article CAS Google Scholar
• Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008; 68: 537–544.
  Article CAS Google Scholar
• Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375–2385.
  Article CAS Google Scholar
• Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD et al. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 2011; 300: 66–78.
  Article CAS Google Scholar
• Hirohashi S . Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333–339.
  Article CAS Google Scholar
• Tsai JH, Yang J . Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27: 2192–2206.
  Article CAS Google Scholar
• Vincent-Salomon A, Thiery JP . Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 2003; 5: 101–106.
  Article CAS Google Scholar
• Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437–449.
  Article CAS Google Scholar
• Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13: 58–68.
  Article Google Scholar
• Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E . TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10: 2462–2477.
  Article CAS Google Scholar
• Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G . A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190–193.
  Article CAS Google Scholar
• Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857–866.
  Article CAS Google Scholar
• Garzon R, Calin GA, Croce CM . MicroRNAs in cancer. Annu Rev Med 2009; 60: 167–179.
  Article CAS Google Scholar
• Kasinski AL, Slack FJ . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849–864.
  Article CAS Google Scholar
• Pencheva N, Tavazoie SF . Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 2013; 15: 546–554.
  Article CAS Google Scholar
• Korpal M, Kang Y . The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008; 5: 115–119.
  Article CAS Google Scholar
• Park SM, Gaur AB, Lengyel E, Peter ME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894–907.
  Article CAS Google Scholar
• Adams BD, Kasinski AL, Slack FJ . Aberrant regulation and function of microRNAs in cancer. Curr Biol 2014; 24: R762–R776.
  Article CAS Google Scholar
• Esquela-Kerscher A, Slack FJ . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.
  Article CAS Google Scholar
• Li G, Luna C, Qiu J, Epstein DL, Gonzalez P . Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem 2010; 285: 5461–5471.
  Article CAS Google Scholar
• Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol 2012; 180: 2440–2451.
  Article CAS Google Scholar
• Guttilla IK, White BA . Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009; 284: 23204–23216.
  Article CAS Google Scholar
• Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL et al. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PloS One 2013; 8: e55502.
  Article CAS Google Scholar
• Huynh C, Segura MF, Gaziel-Sovran A, Menendez S, Darvishian F, Chiriboga L et al. Efficient in vivo microRNA targeting of liver metastasis. Oncogene 2011; 30: 1481–1488.
  Article CAS Google Scholar
• Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 2014; 33: 1287–1296.
  Article CAS Google Scholar
• Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 2009; 106: 1814–1819.
  Article CAS Google Scholar
• Sun Y, Fang R, Li C, Li L, Li F, Ye X et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 2010; 396: 501–507.
  Article CAS Google Scholar
• Kong PZ, Yang F, Li L, Li XQ, Feng YM . Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor. PloS One 2013; 8: e61591.
  Article CAS Google Scholar
• Wang Z, Liu P, Inuzuka H, Wei W . Roles of F-box proteins in cancer. Nat Rev Cancer 2014; 14: 233–247.
  Article CAS Google Scholar
• Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J . Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989–997.
  Article CAS Google Scholar
• Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z et al. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 2013; 57: 610–624.
  Article CAS Google Scholar
• Lo PK, Lee JS, Chen H, Reisman D, Berger FG, Sukumar S . Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas. Exp Mol Pathol 2013; 94: 262–269.
  Article CAS Google Scholar
• Nik AM, Reyahi A, Ponten F, Carlsson P . Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. Gastroenterology 2013; 144: 1001–1011.
  Article CAS Google Scholar
• Wang T, Tamakoshi T, Uezato T, Shu F, Kanzaki-Kato N, Fu Y et al. Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate. Dev Biol 2003; 259: 83–94.
  Article CAS Google Scholar
• Feng X, Wang Z, Fillmore R, Xi Y . MiR-200, a new star miRNA in human cancer. Cancer Lett 2014; 344: 166–173.
  Article CAS Google Scholar
• Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012; 29: 618–626.
  Article CAS Google Scholar
• Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y et al. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol 2013; 43: 548–560.
  Article CAS Google Scholar
• Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208: 875–883.
  Article CAS Google Scholar
• Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res 2012; 40: 499–510.
  Article CAS Google Scholar
• Mizuguchi Y, Specht S, Lunz JG 3rd, Isse K, Corbitt N, Takizawa T et al. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. PloS One 2012; 7: e32449.
  Article CAS Google Scholar
• Pieraccioli M, Imbastari F, Antonov A, Melino G, Raschella G . Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation. Cell Cycle 2013; 12: 2309–2320.
  Article CAS Google Scholar
• Roy SS, Gonugunta VK, Bandyopadhyay A, Rao MK, Goodall GJ, Sun LZ et al. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene 2014; 33: 3707–3716.
  Article CAS Google Scholar
• Akbani R, Ng PK, Werner HM, Shahmoradgoli M, Zhang F, Ju Z et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun 2014; 5: 3887.
  Article CAS Google Scholar
• Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014; 158: 929–944.
  Article CAS Google Scholar